Anúncio
Anúncio

GMED

GMED logo

GLOBUS MEDICAL INC

90.54
USD
Patrocinado
-2.75
-2.95%
07 de jan., 16:00 UTC -5
Encerrado
exchange

Pós-Mercado

98.75

+8.21
+9.07%

Relatórios de Lucros GMED

Rácio de surpresa positiva

GMED separação 26 de 40 últimas estimativas.

65%

Próximo Relatório

Data do Próximo Relatório
10 de fev. de 2026
Estimate for Q4 25 (Revenue/ EPS)
$792.89M
/
$1.11
Mudanças implicadas de Q3 25 (Revenue/ EPS)
+3.10%
/
-5.93%
Mudanças implicadas de Q4 24 (Revenue/ EPS)
+20.63%
/
+32.14%

GLOBUS MEDICAL INC earnings per share and revenue

On 06 de nov. de 2025, GMED reported earnings of 1.18 USD per share (EPS) for Q3 25, beating the estimate of 0.79 USD, resulting in a 47.80% surprise. Revenue reached 769.05 milhão, compared to an expected 749.03 milhão, with a 2.67% difference. The market reacted with a +35.94% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 17 analistas forecast an EPS of 1.11 USD, with revenue projected to reach 792.89 milhão USD, implying an diminuir of -5.93% EPS, and aumentar of 3.10% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
AngioDynamics, Inc.
Report Date
06 de jan. de 2026 Para Q2 26
Estimativa
-$0.10
Real
$0.00
Surpresa
+100.00%
FAQ
For Q3 2025, GLOBUS MEDICAL INC reported EPS of $1.18, beating estimates by 47.8%, and revenue of $769.05M, 2.67% above expectations.
The stock price moved up 35.94%, changed from $61.71 before the earnings release to $83.89 the day after.
The next earning report is scheduled for 10 de fev. de 2026.
Based on 17 analistas, GLOBUS MEDICAL INC is expected to report EPS of $1.11 and revenue of $792.89M for Q4 2025.
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio